Valedictorian Amanda Salinas and Salutatorian Elizabeth Abila, both students from The Academy of Health Science Professions and STEM, will be graduating with their home school, Juarez Lincoln.Salinas has been chosen as 1 of 8 in the state of Texas to receive early admission into the physician assistant program. She will be graduating with her associate degree in biology from STC and 66 college credit hours.

Valedictorian Amanda Salinas, courtesy photo.

I had applied for the program this semester and went through an application process and got an interview at UTRGV, Salinas said. Im really glad that I was able to receive this amazing opportunity because this means that Ill have a secured spot on the masters program once I graduate with my bachelors from UTRGV. Having that spot will bring me one step closer to achieving my career goal of becoming a PA.Salinas has always dreamed of working in the medical field, and this past year opened her eyes and pushed her towards that goal even more.My school really focuses on showing their students the different careers in the medical field, Salinas said. And one of them was a PA. When I learned about being a PA, it really inspired me to want to become one. A recent experience that inspired me more was when my dad and sister got sick with COVID. That experience was terrifying for me because I was so worried about them and if they would get better or not. Thankfully because of my dads physician, they did fully recover. I want to do the same for other families and patients in the future.Despite the health scare in her family, Salinas had the support of her school when things got tough.The academy really shaped me into the person I am today because they always encouraged and supported me in my academics, Salinas said. They encouraged me to take rigorous courses and with the support of my high school I was able to apply to the dual enrollment medical science academy at STC. I was attending high school the first half of my day, and then I would attend STC the second half of my day. This really prepared me for college. Once I finish the program, Ill be going to graduate school at UTRGV as well.Salinas love for her family and her community shows in how hard she has worked to achieve valedictorian and pursue her goals.My family means so much to me, especially now, Salinas said. During the pandemic I learned so many lessons about what it means to be a family and I just really love spending time with them as much as I can. We may face challenges that scare us or try to stop us from accomplishing our goals. But in that case, you really have to persevere through those and make the best of the situation. I think weve all learned that from this past year.Salutatorian Elizabeth Abila has plans to attend Michigan State University and double major in Biochemistry and Molecular Biology.

Salutatorian Elizabeth Abila, courtesy image.

One of the main reasons I chose Michigan State was because I used to have a neighbor that went there, thats how I first heard of it, Abila said. And then I started researching more on the biochemistry program, because thats what I want to major in. They have one of the best in the nation so thats why I decided to apply there, and I got in.Abila credits her future career choice to her kindergarten teacher who went above and beyond for her when she had to miss school for some time.Ive always known that I wanted to be in the medical field since I was in kindergarten, Abila said. I broke my arm when I was in kindergarten and my teacher would always come to my house after school to teach me everything that she taught the class that day so that I wouldnt fail the school year. So that was one of my big influences that kept me going with getting good grades and everything.Abila has a love for children and the medical field and has done exceedingly well first at Juarez Lincoln, and now at the STEM Academy.

I want to be a pediatric heart surgeon, Abila said. My family is really proud of me, especially my mom. Shes telling the whole world.Although school can be tiring and tedious, especially for high achievers, Abila reminds her peers that its not worth it to give up or slack off.You should never give up, Abila said. Even if you feel like you might not get there or if you struggle along the way, at the end of the day, you just need to keep working towards your goals.

Continue reading here:
The Academy of Health Science Professions and STEM fully prepares Val and Sal for future medical field - Progresstimes

NEW BRITAIN, Conn. On a cold January day, a team of four Connecticut National Guard Soldiers make their way down a line of vehicles, helping local residents register for COVID-19 tests.

New Britain Stadium, home of a collegiate summer league baseball team and former minor league home to baseball stars like David Ortiz and Joe Mauer, has seen its parking lot converted into a drive-thru COVID-19 testing site in response to the increase in cases associated with the omicron variant.

Among the soldiers supporting the civilian-led site is Pfc. Stefanie Charpentier, a combat medic assigned to the 141st Medical Company.

I joined the Guard because I always wanted to be in the military, and with the Guard, I could serve close to home while going to college, said Charpentier.

In addition to supporting the states response to the COVID-19 pandemic, Charpentier studies biochemistry at Central Connecticut State University also located in New Britain.

I wanted to be a medic in the Guard and be involved in the medical field on the civilian side as well, said Charpentier. I volunteered for this mission so I could help provide access to medical services that are so critical right now.

Charpentier was also activated in 2021 to help administer the COVID-19 vaccine as part of the Guards efforts at vaccination sites across the state.

As Connecticut grapples with the omicron variant, so far approximately 250 Guardsmen have volunteered to assist 24 testing sites and dispense test kits and masks at five regional points of distribution throughout the state. In addition, Connecticut Guardsmen support logistics operations at the states commodities warehouse in New Britain the hub for testing supplies and PPE distributed statewide.

We train to be ready at a moments notice, and throughout this response, weve used our skills to help the people of Connecticut, said Charpentier. It means a lot that Im able to help people in my state, including right here in New Britain, during this time of need.

Charpentier said she hopes the Guards efforts will help the state get tests for everybody who needs one, and that she is appreciative of the support shown by residents at these testing sites.

The Guard is ready to help, and well continue to do everything we can to support our neighbors here in Connecticut, said Charpentier.

For more National Guard news

National Guard Facebook

National Guard Twitter

More here:
Connecticut Guardsman volunteers to support COVID-19 response | Article | The United States Army - United States Army

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Faze Medicines, a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates, today announced its launch and Series A financing of $81 million. Faze is founded by leading experts in the emerging field of biomolecular condensates with the mission of leveraging this fundamentally new understanding of cell biology to develop therapies to slow, halt or reverse disease pathology. The Series A was led by Third Rock Ventures with Novartis Venture Fund, Eli Lilly and Company, AbbVie Ventures, Invus, Catalio Capital Management, Casdin Capital and Alexandria Venture Investments participating.

Biomolecular condensates are membrane-less clusters of molecules, such as proteins and nucleic acids, that dynamically organize to perform a wide array of cell functions. Research over the past decade, including seminal work by Fazes founders, has found that disturbances in the behavior of condensates play a causative role in myriad human diseases, including amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders. Faze is now poised to deliver medical breakthroughs based on this fundamentally new understanding of cell biology.

The biology of condensates is the kind of science that will rewrite textbooks and, we believe, rewrite medicine, said Cary Pfeffer, M.D., interim chief executive officer of Faze and partner at Third Rock Ventures. Faze is founded by leading experts who have been integral to this field since its very beginnings. Their insights, coupled with the deep expertise of the team we have assembled, will enable us to realize the enormous potential of this new biology.

Cell biology is undergoing a transformation as we come to understand the integral role that biomolecular condensates play within cell processes from DNA repair to intracellular transport, added Rachel Meyers, Ph.D., chief scientific officer of Faze. Faze was founded to translate these exciting discoveries out of the lab and into the clinic, where they could make a real difference in treating diseases that have seen very little therapeutic progress.

The Series A will support Fazes preclinical research in two initial therapeutic focus areas ALS and myotonic dystrophy type 1 (DM1) as well as research to explore condensate biology in other disease areas. In ALS and DM1, a robust body of literature points to a causative role for condensate dysregulation. Leveraging state-of-the-art screening and proteomics techniques, Faze will identify proteins that are key components or regulators of disease-causing condensates, and then employ proprietary assays to discover small molecule drugs targeting these proteins.

Founders and Leadership

Faze is founded by renowned scientific leaders in the field of biomolecular condensates:

Fazes leadership team brings together accomplished biotechnology executives with decades of industry experience and deep scientific, drug discovery and drug development knowledge:

Joining Dr. Pfeffer on the companys inaugural board of directors is:

Faze has additionally established a robust group of expert advisors including those in the areas of drug discovery and clinical development.

About Faze Medicines

Faze Medicines is a biotechnology company harnessing the groundbreaking new science of biomolecular condensates to create medical breakthroughs. Faze was founded by renowned scientific leaders in the field of biomolecular condensates and is supported by a world-class syndicate of investors including Third Rock Ventures, Novartis Venture Fund, Eli Lilly and Company, AbbVie Ventures, Invus, Catalio Capital Management, Casdin Capital and Alexandria Venture Investments. For more information, visit fazemed.com.

Go here to read the rest:
Faze Medicines Launches With $81 Million Series A Financing to Leverage New Biology of Biomolecular Condensates to Treat Disease - Business Wire

The Global Biochemistry Analyzers Market report provides a holistic evaluation of the market for the forecast period (20192025). The report comprises various segments as well as an analysis of the trends and factors that are playing a substantial role in the market. These factors; the market dynamics involve the drivers, restraints, opportunities and challenges through which the impact of these factors in the market are outlined. The drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market. The Global Biochemistry Analyzers Market study provides an outlook on the development of the market in terms of revenue throughout the prognosis period.

In order to present an executive-level model of the market and its future perspectives, the Biochemistry Analyzers Market report presents a clear segmentation based on different parameters. The factors that affect these segments are also discussed in detail in the report.

Major Players included in this report are as follows Abbott, Danaher Corporation, F.Hoffman-La Roche Ltd., Siemens AG, Thermo Fisher Scientific, Inc., Randox Laboratories Ltd., Meril, Hologic Inc., Beckman Coulter Inc., and Horiba Medical.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1873

Biochemistry Analyzers Market: Regional analysis includes:

The study will also feature the key companies operating in the industry, their product/business portfolio, market share, financial status, regional share, segment revenue, SWOT analysis, key strategies including mergers & acquisitions, product developments, joint ventures & partnerships an expansions among others, and their latest news as well. The study will also provide a list of emerging players in the Biochemistry Analyzers Market.

Biochemistry Analyzers Market scope

A basic summary of the competitive landscape A detailed breakdown of the regional expanse A short overview of the segmentation

Furthermore, this study will help our clients solve the following issues:

Cyclical dynamics We foresee dynamics of industries by using core analytical and unconventional market research approaches. Our clients use insights provided by us to maneuver themselves through market uncertainties and disruptions.

Identifying key cannibalizes Strong substitute of a product or service is the most prominent threat. Our clients can identify key cannibalizes of a market, by procuring our research. This helps them in aligning their new product development/launch strategies in advance.

Spotting emerging trends Our Ecosystem offering helps the client to spot upcoming hot market trends. We also track possible impact and disruptions which a market would witness by a particular emerging trend. Our proactive analysis helps clients to have an early mover advantage.

Interrelated opportunities This report will allow clients to make decisions based on data, thereby increasing the chances that the strategies will perform better if not best in the real world.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1873

Some of the Major Highlights of TOC covers:

Biochemistry Analyzers Regional Market Analysis

Biochemistry Analyzers Production by Regions Global Biochemistry Analyzers Production by Regions Global Biochemistry Analyzers Revenue by Regions Biochemistry Analyzers Consumption by Regions

Biochemistry Analyzers Segment Market Analysis (by Type)

Global Biochemistry Analyzers Production by Type Global Biochemistry Analyzers Revenue by Type Biochemistry Analyzers Price by Type

Biochemistry Analyzers Segment Market Analysis (by Application)

Global Biochemistry Analyzers Consumption by Application Global Biochemistry Analyzers Consumption Market Share by Application (2014-2019)

Biochemistry Analyzers Major Manufacturers Analysis

Biochemistry Analyzers Production Sites and Area Served Product Introduction, Application and Specification Biochemistry Analyzers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)Main Business and Markets Served

Key questions answered in the report:

Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/1873

Key Benefits

Major countries in each region are mapped according to individual market revenue. Comprehensive analysis of factors that drive and restrict market growth is provided. The report includes an in-depth analysis of current research and clinical developments within the market. Key players and their key developments in recent years are listed.And More.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. ShahCoherent Market Insights1001 4th Ave, #3200Seattle, WA 98154Tel: +1-206-701-6702Email: sales@coherentmarketinsights.com

Read the original here:
Biochemistry Analyzers Market Incredible Possibilities, Growth with Industry Study, Detailed Analysis and Forecast to 2026 KSU | The Sentinel...

Lorena Infante Lara

Fred Guengerich, who holds the Tadashi Inagami, Ph.D. Chair in Biochemistry and is a professor of biochemistry, and Heidi Hamm, who holds the Aileen M. Lange and Annie Mary Lyle Chair in Cardiovascular Research and is a professor of pharmacology, have been named part of the inaugural class of fellows of the American Society for Biochemistry and Molecular Biology.

The newly established honor recognizes the most distinguished members of the professional society.

The ASBMB is the premier scientific society for biochemistry and molecular biology, so recognition as inaugural fellows is a tremendous honor, said Lawrence J. Marnett, Mary Geddes Stahlman Professor of Cancer Research and dean of basic sciences. Both Heidi and Fred are highly accomplished scientists who have done a great deal for the society throughout their careers. Its hard to imagine two more deserving individuals.

Fellows will receive a crystal award and a pin, and will be recognized with their own profiles on the ASBMB website and at the annual ASBMB meeting, held this year between April 27 and April 30.

Guengerich was nominated by Marnett himself. Dr. Guengerichs extraordinary accomplishments in scientific research are matched only by his devotion to the ASBMB. Guengerich has been an active member of the society since 1978.

For Guengerich, the path was always clear. Ever since I was a sophomore in college, he said, the only career I wanted was to be a biochemist. A native of Pekin, Illinois, Guengerich completed a Ph.D. in biochemistry at Vanderbilt University and returned, after a brief postdoctoral fellowship at the University of Michigan Medical School, to join the faculty of the Department of Biochemistry.

Guengerichs research aims to understand the role of cytochromes P450, or CYPs, as central players in both metabolic and biosynthetic pathways and in drug metabolism related to health and disease. CYP enzymes help detoxicateor remove the harmful effects ofchemical carcinogens and toxicants, and have central roles in hormone synthesis and breakdown. Throughout his academic career, Guengerich has published over 1,000 papers, reviews, and book chapters that have collectively been cited over 100,000 times.

Aside from research excellence, Guengerich is committed to the training of newer generations of biochemists. This commitment to mentoring was rewarded in 2019 with the receipt of the Richard Armstrong Mentoring Award. Among his numerous national and international awards are the William C. Rose Award from the ASBMB, an honorary doctorate from the Universit de Paris, an appointment as one of the inaugural American Chemical Society fellows, an appointment as an American Association for the Advancement of Science fellow, and the receipt of the Award for Outstanding Achievement in Chemistry in Cancer Research from the American Association for Cancer Research.

Following years of service on the editorial board of the Journal of Biological Chemistry, published by ASBMB, he became an associate editor in 2006 and a deputy editor in 2013, a role in which he continues to serve. He also served as interim editor-in-chief in 20152016.

Working with the ASBMB and the Journal of Biological Chemistry has been a great experience for me, Guengerich said. I was very thrilled to be named to the inaugural class of fellows. It really means a lot to me to have come to this point, and I thank everyone along the way.

Hamm was nominated by departmental colleague Tina Iverson, who holds the Louise B. McGavock Chair and is a professor of pharmacology. According to Iverson, Heidis long service to ASBMB, her national contributions to science advocacy, and her stature as a world leader in the field make Hamm an ideal member of the first cohort of ASBMB fellows. Hamm has been a member of ASBMB for many years and served as president of the organization from 2006-2008.

Hamm obtained her Ph.D. training at the University of Texas at Austin. Following a postdoctoral fellowship at the University of WisconsinMadison, she held faculty appointments at the University of Illinois College of Medicine at Chicago and Northwestern University before moving to Vanderbilt in 2000. Her research focus has centered on G protein-coupled receptor signaling, as well as on the structure and function of GTP binding proteins. GTP serves as a source of energy used for signal transduction processes.

While serving as the chair of the Department of Pharmacology between 2000 and 2014, Hamm oversaw an increase in its size and a quintupling of its NIH funding, catapulting it as the top NIH-funded pharmacology department in the nation during her tenure.

Hamms research efforts have been recognized through numerous awards, including the Robert R. Ruffolo Career Achievement Award in Pharmacology from the American Society for Pharmacology and Experimental Therapeutics, the Fritz Lipmann Memorial Lectureship from ASBMB, and the Ariens Award from the Dutch Pharmacological Society. Hamm was also elected a AAAS fellow in 2011.

Its a great honor to be chosen to the inaugural class of ASBMB fellows.ASBMB has been an anchor-point national society throughout my career, and Im excited to be included, said Hamm.

See more here:
Guengerich, Hamm named to inaugural class of ASBMB Fellows - Vanderbilt University News

Pune, India, Dec. 10, 2020 (GLOBE NEWSWIRE) -- The global heparin market size is expected to reach USD 11.43 billion by 2027, exhibiting a CAGR of 3.9% during the forecast period. The market size stood at USD 8.39 billion in 2019. The increasing cases of cardiovascular diseases such as deep vein thrombosis & pulmonary embolism are expected to spur demand for heparin in the forthcoming years, states Fortune Business Insights, in a report. The market size in North America stood at USD 4.28 billion in 2019. The growth in the region is attributed to the prevalence of cardiovascular diseases such as pulmonary embolism. The higher adoption of advanced heparin products will have an excellent effect on the market in the region.

Key Development:

May 2019: Pfizer, Inc. announced that it has received the approval from the U.S. FDA for the administration of its heparin product offering, Fragmin to minimize the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients aged one month and above.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/heparin-market-104447

Rising Incidence of Chronic Disorders to Incite Business Development

The increasing prevalence of cardiovascular diseases around the world, including heart attacks and strokes will spur opportunities for the market. As per the American Heart Association (AHA) Heart Disease and Stroke Statistics, an estimated 5.3 million Americans suffered from atrial fibrillation in 2019.

The growing demand for heparin among patients can have an excellent impact on the market. As per the Centers for Disease Control and Prevention, coronary heart disease is the most common type of heart disease, killing 365,914 people in 2017.4. About18.2 million adultsage 20 and older have CAD (about 6.7%). Moreover, 2 in 10 deaths from CAD happen in adults less than 65 years old. The increasing awareness about the benefits of heparin in the treatment and management of heart diseases will improve the prospects of the market in the foreseeable future.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/heparin-market-104447

Minimal Impact on the Market During COVID-19

The limitations on non-essential medical procedures and consultations has had a drastic impact on the global market amid COVID-19. The healthcare industry has observed a decline in other medical services besides coronavirus. The increased emphasis on COVIDs vaccine has reduced the demand for other therapeutics.

Furthermore, the lack of supply and production of heparin will simultaneously limit the scope of the market. However, government initiatives, including heavy investments and free medical aid will influence the healthy growth of the market in the time of the pandemic.

Inquire Before Buying: https://www.fortunebusinessinsights.com/enquiry/queries/heparin-market-104447

High Adoption of Advanced Products to Boost Market in North America

The market size in North America stood at USD 4.28 billion in 2019. The growth in the region is attributed to the prevalence of cardiovascular diseases such as pulmonary embolism. The higher adoption of advanced heparin products will have an excellent effect on the market in the region.

The increasing healthcare expenditure is expected to foster the healthy growth of the market in North America. The presence of major companies can further enhance the development of the market in the region. Europe is expected to hold the largest share owing to the acceptance of technologically advanced products in the region. The rising number of patients suffering from a range of cardiovascular diseases will further spur opportunities in the region.

Asia Pacific is expected to experience a rapid growth rate owing to the growing patient population. The surging healthcare expenditure in the developing nations will have a tremendous effect on the market in Asia Pacific.

Quick Buy - Heparin Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/104447

The Report Lists the Key Companies in the Heparin Market:

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/heparin-market-104447

Table of Contents:

TOC Continued.!

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/heparin-market-104447

SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

Have a Look at Related Reports:

Infusion Pump Market Share & Industry Analysis, By Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Implantable Pumps, and PCA Pumps), By Application (Diabetes, Oncology, Pain Management, and Others), By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings, and Others), and Regional Forecast, 2019-2026

Medical Carts Market Share & Industry Analysis, By Type (Anesthesia Carts, Emergency Carts, Procedure Carts, Telemedicine Carts and Others), By Material Type (Metal, Plastic, and Others), By End User (Hospitals, Physician Offices, Others) and Regional Forecast, 2019-2026

Population Health Management (PHM) Market Share & Industry Analysis, By Component (Software, and Services), By Platform (Cloud-based, and On-premise), By End User (Healthcare Providers, Healthcare Payers, and Others), and Regional Forecast, 2019-2026

Osteoporosis Treatment Market Share & Industry Analysis, By Drug Class (Bisphosphonate, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator (SERMs), RANK ligand (RANKL) Inhibitor, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Others), and Regional Forecast, 2019-2026

Antiepileptic Drugs (AED) Market Share & Industry Analysis, By Drug Generation (First Generation, Second Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.

Phone:US :+1 424 253 0390UK : +44 2071 939123APAC : +91 744 740 1245Email: sales@fortunebusinessinsights.comFortune Business InsightsLinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/global-heparin-market-10316

Read more:
Heparin Market to Hit USD 11.43 Billion with a CAGR of 3.9% by 2027; Rising Prevalence of Chronic Diseases to Propel Business, states Fortune Business...

ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI) announced today that it will be presenting at the 2nd Annual Glioblastoma Drug Development Virtual Summit. On Wednesday, December 9th, Chief Executive Officer at ITI, Dr. Bill Hearl, will be presenting a talk titled, Adaptive T-cell Immunotherapy for Newly Diagnosed Glioblastoma: Using Targeted Antigen Presentation to Enhance Immune Responses. Dr. Hearl will discuss ITIs investigational platform technology, the companys lead program and its preliminary data in GBM, as well as the companys future focus.

Presentation details are as follows:

Title: Adaptive T-cell Immunotherapy for Newly Diagnosed Glioblastoma: Using Targeted Antigen Presentation to Enhance Immune Responses

Presentation Category: Vaccines

Date and Time: Wednesday, December 9, 2020 12:40 PM EST / 9:40 AM PDT

Location: Virtual Summit

About UNITE

ITIs investigational UNITE platform, or UNiversal Intracellular Targeted Expression, works by fusing pathogenic antigens with the Lysosomal Associated Membrane Protein 1, an endogenous protein in humans, for immune processing. In this way, ITIs vaccines (DNA or RNA) have the potential to utilize the bodys natural biochemistry to develop a broad immune response including antibody production, cytokine release and critical immunological memory. This approach puts UNITE technology at the crossroads of immunotherapies in a number of illnesses, including cancer, allergy and infectious diseases. UNITE is currently being employed in a Phase II clinical trial as a cancer immunotherapy. ITI is also collaborating with academic centers and biotechnology companies to study the use of UNITE in cancer types of high mortality, including cases where there are limited treatment options like glioblastoma and acute myeloid leukemia. ITI believes that these early clinical studies may provide a proof of concept for UNITE therapy in cancer, and if successful, set the stage for future studies, including combinations in these tumor types and others. Preclinical data is currently being developed to explore whether LAMP1 nucleic acid constructs may amplify and activate the immune response in highly immunogenic tumor types and be used to create immune responses to tumor types that otherwise do not provoke an immune response.

About Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc. (ITI) is a privately-held, clinical stage biotechnology company pioneering the development of vaccines through its investigational proprietary technology platform, UNiversal Intracellular Targeted Expression (UNITE), which is designed to utilize the bodys natural biochemistry to develop vaccines that have the potential to generate broad immune responses. The UNITE platform has a robust history of applications in various therapeutic areas, including infectious diseases, oncology, allergy and autoimmune diseases. ITI is primarily focused on applying the UNITE platform to oncology, where it could potentially have broad applications, including targeting viral antigens, cancer antigens, neoantigens and producing antigen-derived antibodies as biologics. In early 2020, an investment of over $60M by HLB Co., LTD, a global pharmaceutical company, enabled ITI to accelerate application of its immuno-oncology platform, in particular to glioblastoma multiforme, and rapidly advance other key candidates in the pipeline, including the most recent initiative into infectious diseases with development of its vaccine candidate for COVID-19. The Company has built a large pipeline from UNITE with eight oncology programs, multiple animal health programs and a SARS-CoV-2 program to prevent and treat COVID-19. ITI has entered into a significant allergy partnership with Astellas Pharma and has formed several academic collaborations with leading Immuno-oncology researchers at Duke University and the University of Florida. ITI maintains its headquarters in Rockville, Maryland. For more information, please visit http://www.immunomix.com.

Read the original:
Immunomic Therapeutics' CEO to Present at the 2nd Annual Glioblastoma Drug Development Summit - Business Wire

While new University of Michigan COVID guidelines are requiring most undergraduates to study from their homes for the winter semester, some classesclasses that are nearly impossible to conduct onlinewill continue to be taught in person.

Biochemistry 352 is one such class. Theres something essential about being in a lab to learn this kind of science, says U-M researcher Neil Marsh.

Srijoni Majhi.

Its the difference between driving a car and reading a book about driving a car. We think of lab experience as being mission-critical to teaching the undergraduates, said Marsh, professor of chemistry in the College of Literature, Science, and the Arts and professor of biological chemistry at Michigan Medicine. We did run remote labs but its a very, very poor substitution for a real lab.

Chemistry, he says, more than other types of science, relies on hands-on learning in the lab. Students in his Biochemistry 352 class learn basic biochemical techniques critical to performing experiments in chemistry. Seemingly straightforward skills such as using pipettes can be more complex when students use the instruments in person.

Of course, the ability to teach students these techniques was upended as the university attempted to deal with the coronavirus pandemic. During the fall semester, just 20% of class credit hours were offered in person.

The chemistry department revamped classes to ensure they met safety protocols. Marshs course includes about 100 students and typically involves a lecture and four sections of labs. Now, Marsh records 15-20 minute videos on certain topics that the students then watch before they attend their lab.

Typically, each of the four lab sections would meet once a week, with 16 students and one graduate student instructor leading the section. Now, only six people are allowed in a labfive students and a graduate instructorat a time. For all of the 100 students in the class to attend lab, extra sections had to be added and students attended lab every other week.

Balancing the desire to offer students hands-on experience and the safety of both graduate instructors and students has been a delicate process. The chemistry department offered students and graduate instructors the choice to attend or teach in person. Students uncomfortable with attending class in person could choose classes that were entirely virtual, and their ability to graduate was not compromised if they did not choose to take an otherwise required lab. The department likewise honored graduate instructors wishes to teach in person or virtually.

A survey was given to graduate student instructors to get their preferences as to whether or not they were willing to teach in person, and the only people that saw the results were the departments associate chair and one staff member, said Robert Kennedy, chair of the Department of Chemistry. The bigger point is that nobody was, or will be in winter, assigned to an in-person section if they do not want to teach an in-person section.

If no instructor wants to teach an in-person lab during the winter, Kennedy says, the department will hold no in-person labs.

In September, the Graduate Employees Organization called a strike to address health and safety concerns for GEO members working on campus. The group called for increased COVID testing, among other considerations. The organization ended its strike Sept. 16, accepting a stronger process to address these concerns. Now, for the winter semester, U-M will pare down the number of students on campus, reducing density in undergraduate residence halls and including increases in asymptomatic testing to detect virus infection.

Srijoni Majhi is one of the graduate students who volunteered to teach a lab section during the fall semester. She says she initially felt hesitant because she didnt want to spread the virus to her labmates and roommates.

Its not me alone. I have a roommate, and then I have my other labmates, Majhi said. If Im exposed, then its certain that the other people will be suffering because of me. But I talked to my labmates and they were very supportive.

Ironically, students may be safest in the biochemistry lab, says Marsh. Lab coats, glovesand goggles have long been required wear, and students, as everywhere on campus, are required to wear masks. Graduate student instructors also disinfect the labs after every class.

Theres also very good ventilation in the lab, Marsh said. In some ways, theyre actually much safer doing our lab course than they are pretty much anywhere else on campus, in terms of risk of exposure to the virus.

Its the ability to teach experiments that Majhi found most necessary in having an in-person labespecially this course, which is a new class. Students are familiar with general chemistry, and some students have already worked in research biology or biochemistry labs in other parts of the university. But for other students, this class is their introduction to the subject.

This is a 300-level course, so the students come very prepared to lab, but there are still students who we still have to help, she said. We have to keep in mind this is a very new biochemistry lab, so many of them are not aware of how to use pipettes or work with enzymes, or other simple techniques.

Jack Toor is an undergraduate who opted to take the in-person lab. A biochemistry major, Toor has done research in the U-M School of Dentistry. The first hands-on experience to surprise him? Pipetting.

We did this experiment in the beginning of our lab which seemed on the surface very lame. It was just learning how to use pipettes, said Toor, who plans to apply to medical school. I have been using those in my dental lab for a very long time, but I had never thought about how accurate they are, even after calibration.

The simple experiment involved asking the students to pipette ever-smaller amounts of waterdown to 20 microliters.

Ive never realized, once you get down to such low volumes, it actually is quite inaccurate, he said.

Another experiment the undergraduates performed was to identify proteins based on their molecular weights. The students put proteins in an acrylamide gel and ran an electric current through the gel. This arranges the proteins in proportion to their mass. Toor said to conduct this experiment himself was more valuable than being given the parameters of the experiment in an online format. After all, experiments shown in a video typically dont contain a blooper reel.

When I took my gel out of its casing, it ripped, and thats something your textbook never talks about, Toor said. I talked to Srijoni about it, who told me after I stained it, I would still be able to piece it back together. Its little things like that that your textbook wouldnt mention.

The changes the chemistry department has had to implement to meet safety requirements do have their silver linings, Marsh says. Although students are in the lab less frequently, the time they spend there might be higher quality. The student-to-teacher ratio is lower, and instead of having to share lab equipment to perform experiments with a partner or group, each student has his or her own equipment.

Now theres a much better teacher-to-student ratio in the lab, and students can really get the attention and help they need. Even though theyre only coming in every other week, we now have enough equipment that every student can do the experiment themselves, Marsh said. Weve also really prioritized the fact that were going to use that whole four-hour period. What weve seen is that the students have come to lab very focused. They really get down and do the work.

Originally posted here:
Difficult Decisions 101: Balancing hands-on learning and safety - University of Michigan News

A new independent global Biochemistry Analysers Market research report by retailer name is a perfect blend of qualitative and quantitative data to make better informed evaluation to analyze competition. The report covers geographic evaluation that comprises areas such as Europe, North America, South America, Asia-Pacific, and essential vendors/players such as Players With number of figures and tables examining the Biochemistry Analysers market, the study offers you a one-stop, visual breakdown of the leading submarkets, products, and market leaders market revenue prediction as well as evaluation for the years to come.

Check discount and get customization for global Biochemistry Analysers market research report @ https://spiremarketresearch.com/report/covid19-impact-biochemistry-analysers-market-295233#inquiry-for-buying

The objective of the global Biochemistry Analysers market research report is to define market sizes of various countries and segments in recent years and to predict the values to the years to come. The report is developed to incorporate both quantitative and qualitative factors of the market within each of the countries and areas comprised in the global Biochemistry Analysers market research report. In addition to this, the report also caters the detailed data about the essential factors such as challenges and driving factors which will define the future development of the market. Moreover, the global Biochemistry Analysers market research report shall also contain available opportunities in micro markets for stakeholders to invest together with the comprehensive study of product offerings and competitive landscape of major players. The detailed sections and sub-sections of the market are explained in the global Biochemistry Analysers market research report.

The global Biochemistry Analysers market research report includes qualitative commentary and exploratory survey on changing market dynamics with market estimates and sizing for business segments, global countries, and applications. The identification of emerging players is completed by listing some of the major industry players.

Thermo Fisher ScientificAbbottHORIBASiemens HealthcareXylem AnalyticsAgappe DiagnosticsRMSMicroLab InstrumentsLabindia Instruments

The Biochemistry Analysers

Get inside scoop of the global Biochemistry Analysers market research report, request for sample @: https://spiremarketresearch.com/report/covid19-impact-biochemistry-analysers-market-295233#request-sample

Recent analysis shows high development emerging leaders and players by market share that are presently attracting exceptional attention. It also motivates managers and executives to study deeply complementary research metric. The evaluations also provide insight into the size and share of different segments in the global -Biochemistry Analysers market. The scope of the global Biochemistry Analysers market research report includes market break-up or segmentation too.

Early buyers are entitled to get discount on standard edition or customization on reports at no added cost. Get more details @ https://spiremarketresearch.com/report/covid19-impact-biochemistry-analysers-market-295233#inquiry-for-buying

The global Biochemistry Analysers market research report mentions examples of different market business strategies and development activities that industry players are accepting to overcome economic challenges and to match demand supply gap. A detailed main business information, company profile, sales, SWOT analysis, average price, revenue, % market share of select players, and gross margin would be available in the global Biochemistry Analysers market research report.

The study also contains the major strategic developments of the market, including new product launch, R&D, agreements, M&A, partnerships, collaborations, regional growth, and joint ventures of the leading competitors active in the market on a regional and global scale.

Go here to read the rest:
The Thorough Analysis Of The Global Biochemistry Analysers market Research During COVID-19 Health Crisis - The Courier

New Jersey, United States: Market Research Intellect has added a new report to its huge database of research reports, entitled Malaysia Automated Biochemical Analyzers Market Size and Forecast to 2027. The report offers a comprehensive assessment of the market including insights, historical data, facts, and industry-validated market data. It also covers the projections using appropriate approximations and methods.

Malaysia Automated Biochemical Analyzers Market Overview

The Malaysia Automated Biochemical Analyzers Market Report provides comprehensive data on market dynamics, market trends, product growth rate, and price. The Malaysia Automated Biochemical Analyzers market report has various facts and statistics assuming the future predictions of the upcoming market participants. In addition, it offers business security taking into account sales, profit, market volume, demand and market supply ratio. The in-depth study provides vital information related to market growth, driving factors, major challenges, opportunities, and threats that will prove to be very helpful for market participants in making upcoming decisions.

Malaysia Automated Biochemical Analyzers Market: Competitive Landscape

The Malaysia Automated Biochemical Analyzers Market report consists of the Competitive Landscape section which provides a complete and in-depth analysis of current market trends, changing technologies, and enhancements that are of value to companies competing in the market. The report provides an overview of sales, demand, futuristic costs and data supply as well as a growth analysis in the forecast year. The key vendors in the market that are performing the analysis are also clearly presented in the report. Their development plans, their growth approaches, and their merger and acquisition plans are also identified. Information specific to a keyword in each of these regions is also provided. This report also discusses the submarkets of these regions and their growth prospects.

Prominent players operating in the market:

Malaysia Automated Biochemical Analyzers Market Segmentation

The report contains the market size with 2019 as the base year and an annual forecast up to 2027 in terms of sales (in million USD). For the forecast period mentioned above, estimates for all segments including type and application have been presented on a regional basis. We implemented a combination of top-down and bottom-up approaches to market size and analyzed key regional markets, dynamics and trends for different applications.

Malaysia Automated Biochemical Analyzers Market Segment by Type:

Malaysia Automated Biochemical Analyzers Market Segment by Application:

Malaysia Automated Biochemical Analyzers Market Regional overview:

In the report, experts analyze and forecast the Malaysia Automated Biochemical Analyzers market on a global as well as regional level. Taking into account all aspects of the market in terms of regions, the focus of the report is on North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The prevailing trends and various opportunities in these regions are studied that can convince the growth of the market in the forecast period 2020 to 2027.

Reasons to Buy the Malaysia Automated Biochemical Analyzers Market Report:

Outlook analysis of the Malaysia Automated Biochemical Analyzers market sector with current trends and SWOT analysis. This study evaluates the dynamics, competition, industrial strategies and strategies of the emerging countries. This report has a comprehensive guide that provides market insights and detailed data on each market segment Market growth factors and risks are presented. More precise information provision on the Malaysia Automated Biochemical Analyzers market for different countries. Provide visions on factors influencing the growth of the market. Market segmentation analysis, including quantitative and qualitative research considering the impact of economic and non-economic aspects Comprehensive company profiles with product offerings, important financial information and the latest developments.

If you have any custom requirements, please let us know and we will offer you the customized report as per your requirements.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Website https://www.marketresearchintellect.com/

Read more:
Malaysia Automated Biochemical Analyzers Market Size, Analysis, Growth, Trends, Outlook And Forecast By 2027 - Khabar South Asia

ICMR National Institute of Immunohaematology (ICMR - NIIH), Department of Health Research, Ministry of Health and Family Welfare, Government of India has invited applications for the Lab Technician, Senior Research Fellow posts on its official website.

ICMR NIIH Recruitment for Lab Technician

ICMR National Institute of Immunohaematology (ICMR - NIIH)Jobs Notification: ICMR National Institute of Immunohaematology (ICMR - NIIH), Department of Health Research, Ministry of Health and Family Welfare, Government of India has invited applications for the Lab Technician, Senior Research Fellow posts. Interested and eligible candidates can apply for ICMR NIIH Recruitment 2020 on or before to 03 December 2020.

Candidates having certain educational qualification including M.Sc. in Life Science/Microbiology/Genetics/Molecular Biotechnology/Biochemistry and 10 + 2 in Sciences can apply for ICMR NIIH Recruitment 2020.

Candidates willing to apply for ICMR NIIH Recruitment 2020 can go through this article for application process, age limit, post wise qualification, experience, selection criteria, how to apply etc here.

Notification details for ICMR NIIH Recruitment 2020:Ref No: ICMR/NIIH/ Advt.1/20-21Date: 23 November 2020

Important Dates for ICMR NIIH Recruitment 2020:Last Date for Submission of Application: 03 December 2020

Vacancy Details for ICMR NIIH Recruitment 2020:Senior Research Fellow-04Lab Technician-01

Eligibility Criteria for ICMR NIIH Recruitment 2020:Educational QualificationSenior Research Fellow-Candidates should have M.Sc. in Life Science/Microbiology/Genetics/Molecular Biotechnology/ Biochemistry with 2 years research experience.Desirable: Experience in Molecular Biology.Lab Technician- 10+ 2 in Science subjects and two years Diploma in Medical LaboratoryTechnology (DMLT)Desirable: B.Sc. Life Science /Microbiology/Biochemistry/Biotechnology.Candidates should check the notification link for details of the Educational Qualification of the Posts.

Age Limit (As on 01 December 2020) for ICMR NIIH Recruitment 2020:Senior Research Fellow-28 yearsLab Technician- 30 yearsAge relaxation for SC/OBC/PWD and Experience candidate will be as per the rules.

ICMR NIIH Recruitment 2020: PDF

How to Apply for ICMR NIIH Recruitment 2020:Interested and eligible candidates can download the application from the official website -http://www.niih.org.in and fill it with his/her own handwriting and send the same to the mail id- estniih1310@gmail.com on or before 03 December 2020. Please check the short notification for details in this regard.

Link:
ICMR NIIH Recruitment 2020 for Lab Technician and other Posts @main.icmr.nic.in, Check Eligibility/Application Process Here - Jagran Josh

UO biophysical chemist Peter von Hippel has been recognized as the 2021 recipient of the Ignacio Tinoco Award from the Biophysical Society for his exceptional contributions to the field of biophysics.

An emeritus professor in the Department of Chemistry and Biochemistry and a member of the Institute of Molecular Biology, von Hippel has spent decades developing approaches to studying the molecular basis of gene expression and played a leading role in creating the major discipline of modern molecular biophysics.

The award really honors all the great people who have worked in my lab over the last 50 years and in many cases have subsequently gone on to having successful scientific careers of their own, von Hippel said.

Named after the late Ignacio Nacho Tinoco, a pioneering biophysicist, educator and mentor at the University of California, Berkeley, the Tinoco Award recognizes investigators in the field of biophysics who have made major scientific contributions, while also maintaining collaborative, inclusive and engaging environments.

Von Hippel has mentored, educated and inspired many students and colleagues over the years, say those who know him, such as Andy Marcus, a professor in the Department of Chemistry and Biochemistry. Marcus has worked with von Hippel in recent years to develop new approaches to studying the mechanisms and dynamics of the central biological processes of DNA transcription and replication.

Its really not possible to overstate the significance of Pete von Hippels scientific impact over the course of his 50-plus-year career, Marcus said. He is an accomplished leader in every sense of the word. In spite of his huge scientific stature, Pete is remarkably modest.To interact with him scientifically is an enriching experience because henaturallyworks to elevate everyone around him.

After finishing his doctorate at Massachusetts Institute of Technology in 1955, von Hippel became a researcher, as well as a commissioned officer in the U.S. Navy, at the Naval Medical Research Institute in Bethesda, Maryland. In 1959 he became an assistant, and then an associate, professor in the Department of Biochemistry at Dartmouth Medical School in Hanover, New Hampshire.

He moved to Oregon in 1967 to continue his National Institutes of Health- and National Science Foundationsupported research and teaching in the fields of biophysical chemistry and molecular biology. He was honored by election to the National Academy of Sciences in 1978, to the American Academy of Arts and Sciences in 1979 and to the American Philosophical Society in 2004. He was also appointed a Career American Cancer Society Research Professor in 1989.

Von Hippel uses physical biochemical approaches to study the molecular basis of gene expression. As Marcus describes it, von Hippel is largely responsible for writing the modern "rule book to understand the physical-chemical basis of how genetic macromolecules, like DNA and RNA, carry out their biological functions and is recognized by biochemists and biophysicists around the world for his pioneering work.

Bruce Blonigen, dean of the College of Arts and Sciences, pointed to the significant impact of von Hippels hundreds of published research papers and the numerous high-level research grants he has received over the years.

Even more extraordinary is the significance of the discoveries he has made and how it has advanced our knowledge of the molecular basis of gene expression, Blonigen said. Im thrilled that his career achievements have been recognized by this award.

Excerpt from:
UO's von Hippel receives Biophysical Society award | Around the O - AroundtheO

UC President Michael V. Drake, M.D., and UC Board of Regents Chair John A. Prez invite you to a virtual event:

UCs 2020 Nobel Prize winners on changing the world through scientific discoveryThursday, December 3, 20201:00 2:00 PM P.T.

Join us as we celebrate the University of Californias newest Nobel laureates and hear their reflections on the value of scientific discovery and its momentous impact on society. The discussion will highlight the role of research in understanding our world, improving our quality of life, and informing critical public policy decisions.

Learn how UC is cultivating a culture of opportunity and discovery, supporting women in science, and fostering the next generation of innovators.

Michael V. Drake, M.D.President, University of California

John A. PrezChair of the UC Board of Regents

Honoring UCs four 2020 Nobel Prize winners:

Jennifer DoudnaProfessor, biochemistry and molecular biology, UC Berkeley

Reinhard GenzelProfessor emeritus of physics, UC Berkeley, and director of the Max Planck Institute for Extraterrestrial Physics

Andrea GhezProfessor, physics and astronomy, UCLA

Charles RiceUC Davis alumnus and professor of virology, The Rockefeller University

Continue reading here:
In conversation: UC's 2020 Nobel Prize winners on changing the world through scientific discovery - University of California

18-Nov-2020

Ingredients | Marketing

The company's active ingredient product lines meet consumer expectations of quality, performance andsustainability

Based on its recent analysis of the global personal care active ingredients market, Frost & Sullivan recognises Mibelle AG Biochemistry with the 2020 Global Company of the Year Award.

It has successfully introduced several breakthrough sustainable active ingredients, whose efficacy is supported by in-vivo and in-vitro study results. Mibelle Biochemistry is a pioneer with regards to using senolytics to delay skin aging in cosmetic applications, which has helped the company achieve a leading positioning in the market.

"Demonstrating its expertise in recognising the dynamic needs of the cosmetics industry, Mibelle Biochemistry launched the Alpine Rose Active ingredient to fight skin aging," said Prateeksha Kaul Research Analyst.

"This ingredient contains a natural senolytic agent extracted from the Alpine rose leaves in the Swiss Alps to eliminate senescent cells, which are the cells responsible for ageing, without affecting the neighboring cells.

"This halts the skins aging process while rejuvenating it and increasing its elasticity. This active also meets the rising demand fornatural and sustainable products over harsh chemicals that are harmful to both the environment and the skin."

Similarly, in response to the growing interest in phytocannabinods, Mibelle Biochemistry introduced an encapsulated cannabidiol (CBD) ingredient, the Lipobelle Pino C. Other players in the market have had limited success with CBD in spite of its potential benefits for the skin because it is not soluble in water.

Mibelle addressed this limitation with the Lipobelle Pino C. By encapsulating the CBD into a nanoemulsion using hemp oil, Mibelle made it water-soluble and stable in cosmetic formulations.

Its combination with an extract from Swiss stone pines also helps the product fight inflammation. Lipobelle Pino C exploits the anti-inflammatory and regenerating effects of CBD for cosmetic benefits such as easing facial tension, reducing inflammation, and regenerating tissue.

Mibelle Biochemistry has been a pioneer in utilising interesting biochemical concepts for its active ingredients. In 2008, it gained a first-mover advantage with the launch of its active ingredient PhytoCellTec Malus Domestica, which involved the application of stem cells in cosmetics for the very first time.

In 2019, Mibelle utilised its PhytoCellTec technology to launch the PhytoCellTec Goji, which stimulates the mesenchymal stem cell (MSC) culture with goji stem cells for enhancing face shape by preventing the skin from sagging. The success of this technology and other recent innovations has allowed the company to achieve a 15 percent growth rate annually.

Each year, Frost & Sullivan presents a Company of the Year award to the organisation that demonstrates excellence in terms of growth strategy and implementation in its field.

The award recognises a high degree of innovation with products and technologies, and the resulting leadership in terms of customer value and marketpenetration.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development.

Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

Read the original here:
Mibelle Biochemistry announces: Mibelle Biochemistrys Ability to Introduce Breakthrough Active Ingredients for the Personal Care Market by Frost and...

If youre preparing for theMedical College Admission Test(MCAT),you are going to want to consult the experts. These selections from Kaplans MCATQuestion of the Day seriescan help you sharpen your skills as you prepare to begin your potential journey into medical training.

The questions below come from three of the four MCAT sectionsbiological and biochemical foundations of living systems; chemical and physical foundations of biological systems; and psychological, social, and biological foundations of behavior. A fourth section, critical analysis and reasoning skills (commonly referred to as CARS), is based largely on inference.

Medicine can be a career that is both challenging and highly rewarding but figuring out a medical schools prerequisites and navigating the application process can be a challenge unto itself. For studentspreparing for the medical school, theAMA premed glossary guidehas the answers to frequently asked questions,

For those already in medical school, the AMA selected Kaplan as apreferred providerto support you in reaching your goal of passing the USMLEor COMLEX-USA.AMA members can save 30% on access to additional study resources, such as KaplansQbankand High-yield courses.

Section: Biological and biochemical foundations of living systems

Question: Which of the following characteristics is NOT attributed to antibodies?

A. Antibodies bind to more than one distinct antigen.

B. Antibodies label antigens for targeting by other immune cells.

C. Antibodies can cause agglutination by interaction with antigen.

D. Antibodies have two heavy chains and two light chains.

The correct answer is A.

Kaplan explains why: Antibodies are specific to a single antigen. Each B-cell produces a single type of antibody with a constant region that is specific to the host and a variable region that is specific to an antigen.

Section: Chemical and physical foundations of biological systems

Question: Photons and other energy sources can excite electrons into higher energy levels, though these excitations are typically short-lived. X-ray imaging succeeds because different tissue types are differently able to absorb the energy of a photon in order to excite an electron. Suppose an electron falls from n = 4 to its ground state, n = 1. Which of the following effects is most likely?

A. A photon is absorbed.

B. A photon is emitted.

C. The electron moves into a p-orbital.

D. The electron moves into a d-orbital.

The correct answer is B.

Kaplan explains why: Because the electron is moving into the n = 1 shell, the only subshell available is the 1s subshell, which eliminates choices (C) and (D). There will be some energy change, however, as the electron must lose energy to return to the minimum-energy ground state. That will require emitting radiation in the form of a photon.

Section: Psychological, social, and biological foundations of behavior

Question: A stroke patient comprehends speech but cannot move her mouth to form words. Which of the following brain areas is likely affected?

A. Brocas area

B. Wernickes Area

C. Arcuate fasciculus

D. Superior temporal gyrus

The correct answer is A.

Kaplan explains why: Brocas area governs the motor function of language. A stroke that affects Brocas area will leave receptive language intact, but word formation will be affected. A stroke affecting Wernickes area, choice (B), will make it so the individual is unable to comprehend speech. A stroke affecting the arcuate fasciculus, choice (C), will result in an inability to repeat words heard but spontaneous language production is intact. The superior temporal gyrus, choice (D), is where Wernickes area is located.

Continue reading here:
November 2020: Kaplan MCAT stumpers put premeds to the test - American Medical Association

A new informative report on the global Biochemical Reagent market titled as, Biochemical Reagent has recently published by Global Market Vision to its humongous database which helps to shape the future of the businesses by making well-informed business decisions. It offers a comprehensive analysis of various business aspects such as global market trends, recent technological advancements, market shares, size, and new innovations. Furthermore, this analytical data has been compiled through data exploratory techniques such as primary and secondary research. Moreover, an expert team of researchers throws light on various static as well as dynamic aspects of the global Biochemical Reagent market.

The global Biochemical Reagent market was xx million US$ in 2019 and is expected to xx million US$ by the end of 2027, growing at a CAGR of xx% between 2020 and 2027.

Request Sample Copy of this Report @: https://www.globalmarketvision.com/sample_request/15506

The global Biochemical Reagent market has been inspected at the domestic and global platform for better understanding of competitive landscape. It has been examined with SWOT and Porters five-technique. For effective business outlook, it offers detailed elaboration on some significant sales strategies as well as marketing channel carried out by successful industries. The Biochemical Reagent Market report covers all key parameters such as product innovation, market strategy for leading companies, Biochemical Reagent market share, revenue generation, the latest research and development and market expert perspectives.

The Top Key Players include: Thermo Fisher Scientific, Beckman Coulter, Abbott, Merck & Co., Inc., Life Technologies, Bio-Rad, Water Corporation, Sigma-Aldrich, Agilent Technologies Inc., Betcon Dickinson, Roche, AB Analitica, Gesan Production, Medicalsystem Biotechnology Co., Ltd., Promega, PZ CorAugust, SENTINEL CH., Teco Diagnostics, Dickinson & Company

North America, Latin America, Middle East, Asia-Pacific, Africa, Europe have been analyzed to study the global Biochemical Reagent market. Leading key players have been analyzed in several global regions. Furthermore, it makes use of graphical presentation techniques such as graphs, charts, tables, and pictures for better understanding to readers.

Request Discount on This Report @: https://www.globalmarketvision.com/check-discount/15506

Synopsis of the competitive landscape

The reports conclusion leads into the overall scope of the global market with respect to feasibility of investments in various segments of the market, along with a descriptive passage that outlines the feasibility of new projects that might succeed in the global Biochemical Reagent market in the near future. The report will assist understand the requirements of customers, discover problem areas and possibility to get higher, and help in the basic leadership manner of any organization. It can guarantee the success of your promoting attempt, enables to reveal the clients competition empowering them to be one level ahead and restriction losses.

Global Biochemical Reagent Market Segmentation:

By Type/Product, Biochemical Reagent market has been segmented into: Chromatography, Mass Spectrometry, Electrophoresis,

By Application/End User, Biochemical Reagent has been segmented into: Protein Synthesis and Purification, Gene Expression, DNA and RNA Analysis, Drug Testing,

Major questions addressed through this global research report:

Table of Content (TOC):

Chapter 1 Introduction and Overview

Chapter 2 Industry Cost Structure and Economic Impact

Chapter 3 Rising Trends and New Technologies with Major key players

Chapter 4 Global Biochemical Reagent Market Analysis, Trends, Growth Factor

Chapter 5 Biochemical Reagent Market Application and Business with Potential Analysis

Chapter 6 Global Biochemical Reagent Market Segment, Type, Application

Chapter 7 Global Biochemical Reagent Market Analysis (by Application, Type, End User)

Chapter 8 Major Key Vendors Analysis of Biochemical Reagent Market

Chapter 9 Development Trend of Analysis

Chapter 10 Conclusion

Quick Buy@: https://www.globalmarketvision.com/checkout/?currency=USD&type=single_user_license&report_id=15506

Any special requirements about this report, please let us know and we can provide custom report.

See the original post here:
Due to the Outbreak of COVID-19, Biochemical Reagent Market By Top Leading Players Thermo Fisher Scientific, Beckman Coulter, Abbott, Merck & Co....

This article was originally published here

Front Med (Lausanne). 2020 Oct 22;7:584112. doi: 10.3389/fmed.2020.584112. eCollection 2020.

ABSTRACT

Introduction: COVID-19 is a novel and devastating disease. Its manifestations vary from asymptomatic to lethal. Moreover, mortality rates differ based on underlying health conditions and ethnicity. We investigated the biochemical rationale behind these observations using machine reasoning by the sci.AI system (https://sci.ai/). Facts were extracted and linked from publications available in nlm.nih.gov and Europe PMC to form the dataset which was validated by medical experts. Results: Based on the analysis of experimental and clinical data, we synthesized detailed biochemical pathways of COVID-19 pathogenesis which were used to explain epidemiological and clinical observations. Clinical manifestations and biomarkers are highlighted to monitor the course of COVID-19 and navigate treatment. As depicted in the Graphical Abstract, SARS-CoV-2 triggers a pro-oxidant (PO) response leading to the production of reactive oxygen species (ROS) as a normal innate defense. However, SARS-CoV-2s unique interference with the antioxidant (AO) system, through suppression of nitric oxide (NO) production in the renin- angiotensin-aldosterone system (RAAS), leads to an excessive inflammatory PO response. The excessive PO response becomes critical in cohorts with a compromised AO system such as patients with glucose-6-phosphate dehydrogenase deficiency (G6PDd) where NO and glutathione (GSH) mechanisms are impaired. G6PDd develops in patients with metabolic syndrome. It is mediated by aldosterone (Ald) which also increases specifically in COVID-19. Conclusion: G6PD is essential for an adequate immune response. Both G6PDd and SARS-CoV-2 compromise the AO system through the same pathways rendering G6PDd the Achilles heel for COVID-19. Thus, the evolutionary antimalarial advantage of the G6PDd cohort can be a disadvantage against SARS-CoV-2.

PMID:33195336 | PMC:PMC7643021 | DOI:10.3389/fmed.2020.584112

View original post here:
Centrality of G6PD in COVID-19: The Biochemical Rationale and Clinical Implications - DocWire News

Global Bench-top Automated Biochemical Analyzers Market Research report 2021 provides overview including size, share, industry growth, product scope, development plans, regions trends, consumptions, demand factors, types and application and value chain structure. The Global Bench-top Automated Biochemical Analyzers analysis is also provided for the international markets including market opportunities, investment plans, historical data and research expert opinions.

Download Sample Copy of This Report @ https://www.theinsightpartners.com/sample/TIPRE00021644/

Development policies, investment plans, cost structures, capacity are discussed as well as growth rate, manufacturing processes, economic growth are analyzed. This research report also states import/export data, industry supply and consumption figures as well as cost structure, price, industry revenue (Million USD) and gross margin by regions like (North America, Europe, China, Japan, Southeast Asia, India, and Central & South America etc.)

The report also includes the profiles of key players in bench-top automated biochemical analyzers market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. ThermoFisher Scientific Abaxis, Inc Elitech Shandong Gaomi Caihong Sunostik Medical Technology Sysmex Horiba Medical Tecom Science Randox Laboratories Dirui

The research study is a highly acclaimed resource that investors, market contestants, and other people interested in this Bench-top Automated Biochemical Analyzers report can use to intensely position themselves in the global Bench-top Automated Biochemical Analyzers market. It mentions the recent development structures, future growth plans, and other significant aspects of the business key participants that define their growth in the global Bench-top Automated Biochemical Analyzers market.

Bench-top Automated Biochemical Analyzers Market Important Factors:

Bench-top Automated Biochemical Analyzers Industry research report is a meticulous investigation of the current scenario of the Bench-top Automated Biochemical Analyzers global and regional market, which covers several industry dynamics. The Bench-top Automated Biochemical Analyzers market research report is a resource, which provides current as well as upcoming technical and financial details with market risk, growing demand and raw materials. The thorough analysis in this report enables investors, CEOs, regional traders, suppliers, top vendors to understand the market in a better way and based on that knowledge make well-informed decisions.

Place a Direct Order of this Report https://www.theinsightpartners.com/buy/TIPRE00021644/

Note: If you have any special requirements related to Bench-top Automated Biochemical Analyzers Market Report please let us know and we will offer you the report as you want.

About us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defence.

Contact us:

Call: +1-646-491-9876

Email: [emailprotected]

More here:
Analyzing Impacts Of COVID-19 On Bench-top Automated Biochemical Analyzers Market Effects, Aftermath And Forecast To 2028 - Clark County Blog

This fall, the University of Georgia welcomed 20 of the top students from around the nation into its incoming class for 2020-2021 through the Foundation Fellowship, the highest academic scholarship the university awards.

These new Foundation Fellows had an average SAT of 1544, an average ACT of 34.9 and an average high school GPA of 4.21 on a 4.0 scaleextra points indicate advanced placement courses.

Administered by the UGA Honors Program, the Foundation Fellowship was created in 1972 by trustees of the UGA Foundation to enrich the educational experience of outstanding undergraduates. This years recipients were selected from 800-plus applicants.

Through the Fellowship, in-state students receive an annual stipend of $12,400 and the Zell Miller Scholarship. Out-of-state students receive an annual stipend of $20,400 and out-of-state tuition waivers. In addition to group travel-study experiences, including a Maymester study abroad at Oxford University and three spring trips, Fellows also receive individual travel grants and funding for research and academic conference attendance.

The 20 new Foundation Fellows, listed below with their high school, hometown and major, bring the total number of current recipients to 97.

The Foundation Fellows are enrolled in the UGA Honors Program, which had 718 new students this fall. Overall, new Honors students had an average high school GPA of 4.06, an average SAT of 1517 and an average ACT of 34 (English and math only).

For more information about the UGA Honors Program and the scholarships it administers, visit https://honors.uga.edu/.

Read more here:
UGA names 20 new Foundation Fellows - University of Georgia

Global Biochemical Reagent market forecast 2020-2026 tracks the latest market dynamics, such as driving factors, restraining factors, and industry news like mergers, acquisitions, and investments. It provides market size (value and volume), market share, growth rate by types, applications, and combines both qualitative and quantitative methods to make micro and macro forecasts in different regions or countries.

The Biochemical Reagent market size reports can help to understand the market and strategize for business expansion accordingly. In the strategy analysis, it gives insights from marketing channel and market positioning to potential growth strategies, providing in-depth analysis for new entrants or exists competitors in the Biochemical Reagent market industry.

Get a Sample Copy of the report:https://www.reporthive.com/request_sample/2469931

Major players covered in this report:

Thermo Fisher ScientificBeckman CoulterAbbottMerck & Co., Inc.Life TechnologiesBio-RadWater CorporationSigma-AldrichAgilent Technologies Inc.Betcon DickinsonRocheAB AnaliticaGesan ProductionMedicalsystem Biotechnology Co., Ltd.PromegaPZ CorAugustSENTINEL CH.Teco DiagnosticsDickinson & Company

Biochemical Reagent market by Types:

Chromatography ReagentsElectrophoresis ReagentsMass SpectrometryPCR Reagent KitsCell and Tissue Culture Reagents

Biochemical Reagent market by Applications:

Protein Synthesis and PurificationGene ExpressionDNA and RNA AnalysisDrug Testing

Inquire or share your questions if any before the purchasing this report @https://www.reporthive.com/request_customization/2469931

Geographically, the regional consumption and value analysis by types, applications, and countries are included in the report. Furthermore, it also introduces the major competitive players in these regions.

Major regions covered in the report:-North America-Europe-Asia-Pacific-Latin America-Middle East & Africa

Detailed TOC of Global Biochemical Reagent market:1 Market Overview1.1Biochemical Reagent market Introduction1.2 Market Analysis by Type1.2.1 Type 11.2.2 Type 21.3 Market Analysis by Application1.3.1 Application 11.3.2 Application 21.4 Market Analysis by Region1.4.1 United States Market States and Outlook (2014-2026F)1.4.2 Europe Market States and Outlook (2014-2026F)1.4.3 China Market States and Outlook (2014-2026F)1.4.4 Japan Market States and Outlook (2014-2026F)1.4.5 Southeast Asia Market States and Outlook (2014-2026F)1.5 Market Dynamics and Development1.5.1 Merger, Acquisition and New Investment1.5.2 Market SWOT Analysis1.5.3 Drivers1.5.4 Limitations1.5.5 Opportunities and Development Trends1.6 Global Market Size Analysis from 2014 to 20261.6.1 Global Market Size Analysis from 2014 to 2026 by Consumption Volume1.6.2 Global Market Size Analysis from 2014 to 2026 by Value1.6.3 Global Price Trends Analysis from 2014 to 20262 Global Biochemical Reagent market Competition by Types, Applications, and Top Regions and Countries2.1 Global Biochemical Reagent market(Volume and Value) by Type2.1.1 Global Biochemical Reagent market Consumption and Market Share by Type (2014-2019)2.1.2 Global Biochemical Reagent market Revenue and Market Share by Type (2014-2019)2.2 Global Biochemical Reagent market(Volume and Value) by Application2.2.1 Global Biochemical Reagent market Consumption and Market Share by Application (2014-2019)2.2.2 Global Biochemical Reagent market Revenue and Market Share by Application (2014-2019)2.3 Global Biochemical Reagent market(Volume and Value) by Region2.3.1 Global Biochemical Reagent market Consumption and Market Share by Region (2014-2019)2.3.2 Global Biochemical Reagent market Revenue and Market Share by Region (2014-2019)

About us:

Our research base consists of a wide spectrum of premium market research reports. Apart from comprehensive syndicated research reports, our in-house team of research analysts leverages excellent research capabilities to deliver highly customized tailor-made reports. The market entry strategies presented in our reports has helped organizations of all sizes to generate profits by making timely business decisions. The research information including market size, sales, revenue, and competitive analysis offered, is the product of our excellence in the market research domain.

Read the original:
COVID-19 Impact ON Biochemical Reagent Market Manufacturers Analysis And Industry Insights 2020-2026 | Thermo Fisher Scientific, Beckman Coulter,...